NCT07414680 Integrating Systematic Data of Medicine to Explore the Solution for Healthy Aging (ISDHA) Phase 4
| NCT ID | NCT07414680 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Sleep Disturbance |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2026-09-15 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2026-09-15 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to build up the comprehensive health database of geriatric medicine for middle-aged and elderly people in Taiwan.
Eligibility Criteria
Inclusion Criteria: * Willing to sign a written participant consent form. * Males or females aged 40 or above who have participated in the "Integrated Systematic Geriatric Medical Information to Explore Solutions for Healthy Aging (Pilot Project)," the "Integrated Systematic Geriatric Medical Information to Explore Solutions for Healthy Aging" master planner, or the "Integrated Systematic Medical Information to Explore Solutions for Healthy Aging" project (not subject to exclusion criteria). * Males or females aged 40-59 who have participated in health checkups for employees of Chang Gung Memorial Hospital, Formosa Plastics Group, or Chang Gung University. * Those with a medical record of more than one year at Chang Gung Memorial Hospital. * Those who have resided in Taiwan for more than 180 days in the past year. Exclusion Criteria: * Individuals with severe organ abnormalities, such as: heart failure (NYHA Fc ≥ III), chronic obstructive pulmonary disease (hospitalization/emergency room visit or medication adjustment within the past month due to disease worsening), decompensated cirrhosis, hemodialysis, or currently undergoing cancer treatment. * Individuals with a history of severe autoimmune diseases. * Individuals with a preliminary cognitive and mental assessment score of \<26 on the Mini-Mental State Examination (MMSE) or ≥5 on the Generalized Depression Scale (GDS). * Individuals (who agree to undergo brain MRI) who are deemed unsuitable for MRI after evaluation (e.g., those with pacemakers, cochlear implants, or spatial phobia). * Individuals who have taken antibiotics within the past month. * Individuals whose hearing, vision, or cognitive impairments affect communication. * Individuals unable to stand or walk (with a walking aid) or with unsteady gait when walking. * Those who have undergone follow-up outpatient assessments that may affect cognitive function, including but not limited to stroke, Parkinson's syndrome, Parkinson's dementia, epilepsy, brain tumor, or a history of mental illness such as schizophrenia, severe depression, bipolar disorder, alcohol or drug abuse, or a history of loss of consciousness due to severe head trauma. * Those currently diagnosed with depression and undergoing treatment. * Those with a past medical history confirming dementia, depression, etc.. * Those deemed unsuitable by a physician.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07414680 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Sleep Disturbance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07414680 currently recruiting?
Yes, NCT07414680 is actively recruiting participants. Contact the research team at fangjits@cgmh.org.tw for enrollment information.
Where is the NCT07414680 trial being conducted?
This trial is being conducted at Taipei, Taiwan, Taoyuan, Taiwan.
Who is sponsoring the NCT07414680 clinical trial?
NCT07414680 is sponsored by Chang Gung Memorial Hospital. The trial plans to enroll 250 participants.